Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MELINTA THERAP

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 48
  • 0 comments

FDA approve ORITAVANCIN DIPHOSPHATE

Comment Full text

RISING

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 66
  • 0 comments

FDA approve DAPSONE

Comment Full text

HIKMA

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 86
  • 0 comments

FDA approve DANTROLENE SODIUM

Comment Full text

CHARTWELL RX

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 67
  • 0 comments

FDA approve DAPSONE

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 63
  • 0 comments

FDA approve NALOXONE HYDROCHLORIDE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 71
  • 0 comments

FDA approve LETROZOLE

Comment Full text

OTSUKA

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 62
  • 0 comments

FDA approve TOLVAPTAN

Comment Full text

NOSTRUM LABS INC

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 89
  • 0 comments

FDA approve DAPSONE

Comment Full text

TARO

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 55
  • 0 comments

FDA approve DAPSONE

Comment Full text

RISING

  • FDA Approval
  • April 28, 2025, 08:46 UTC
  • 67
  • 0 comments

FDA approve SEVELAMER CARBONATE

Comment Full text
  • Previous
  • 192
  • 193
  • 194
  • 195
  • 196
  • Next

Search

News categories

  • Technical Exchange News(13517)
  • Event(6229)
  • SEC News(351094)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192834)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin